Inducing thyrotoxicosis in the liver to treat raised cholesterol

Lancet Diabetes Endocrinol. 2014 Jun;2(6):438-9. doi: 10.1016/S2213-8587(14)70026-9. Epub 2014 Feb 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anilides / therapeutic use*
  • Anticholesteremic Agents / therapeutic use*
  • Chemical and Drug Induced Liver Injury / epidemiology*
  • Cholesterol, LDL / drug effects*
  • Female
  • Humans
  • Hyperlipoproteinemia Type II / drug therapy*
  • Liver / drug effects*
  • Male

Substances

  • 3-((3,5-dibromo-4-(4-hydroxy-3-(1-methylethyl)phenoxy)phenyl)amino)-3-oxopropanoic acid
  • Anilides
  • Anticholesteremic Agents
  • Cholesterol, LDL